These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 27753007)
1. Combination Chemistry: Structure-Activity Relationships of Novel Psychoactive Cannabinoids. Wiley JL; Marusich JA; Thomas BF Curr Top Behav Neurosci; 2017; 32():231-248. PubMed ID: 27753007 [TBL] [Abstract][Full Text] [Related]
2. AB-CHMINACA, AB-PINACA, and FUBIMINA: Affinity and Potency of Novel Synthetic Cannabinoids in Producing Δ9-Tetrahydrocannabinol-Like Effects in Mice. Wiley JL; Marusich JA; Lefever TW; Antonazzo KR; Wallgren MT; Cortes RA; Patel PR; Grabenauer M; Moore KN; Thomas BF J Pharmacol Exp Ther; 2015 Sep; 354(3):328-39. PubMed ID: 26105953 [TBL] [Abstract][Full Text] [Related]
3. Moving around the molecule: relationship between chemical structure and in vivo activity of synthetic cannabinoids. Wiley JL; Marusich JA; Huffman JW Life Sci; 2014 Feb; 97(1):55-63. PubMed ID: 24071522 [TBL] [Abstract][Full Text] [Related]
4. Cannabinoids in disguise: Δ9-tetrahydrocannabinol-like effects of tetramethylcyclopropyl ketone indoles. Wiley JL; Marusich JA; Lefever TW; Grabenauer M; Moore KN; Thomas BF Neuropharmacology; 2013 Dec; 75():145-54. PubMed ID: 23916483 [TBL] [Abstract][Full Text] [Related]
5. Analysis of the pharmacological properties of JWH-122 isomers and THJ-2201, RCS-4 and AB-CHMINACA in HEK293T cells and hippocampal neurons. Costain WJ; Rasquinha I; Comas T; Hewitt M; Aylsworth A; Rouleau Y; Marleau V; Soo EC; Tauskela JS Eur J Pharmacol; 2018 Mar; 823():96-104. PubMed ID: 29408093 [TBL] [Abstract][Full Text] [Related]
6. Thermolytic Degradation of Synthetic Cannabinoids: Chemical Exposures and Pharmacological Consequences. Thomas BF; Lefever TW; Cortes RA; Grabenauer M; Kovach AL; Cox AO; Patel PR; Pollard GT; Marusich JA; Kevin RC; Gamage TF; Wiley JL J Pharmacol Exp Ther; 2017 Apr; 361(1):162-171. PubMed ID: 28087785 [TBL] [Abstract][Full Text] [Related]
7. Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA. Banister SD; Moir M; Stuart J; Kevin RC; Wood KE; Longworth M; Wilkinson SM; Beinat C; Buchanan AS; Glass M; Connor M; McGregor IS; Kassiou M ACS Chem Neurosci; 2015 Sep; 6(9):1546-59. PubMed ID: 26134475 [TBL] [Abstract][Full Text] [Related]
8. Effects of bioisosteric fluorine in synthetic cannabinoid designer drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135. Banister SD; Stuart J; Kevin RC; Edington A; Longworth M; Wilkinson SM; Beinat C; Buchanan AS; Hibbs DE; Glass M; Connor M; McGregor IS; Kassiou M ACS Chem Neurosci; 2015 Aug; 6(8):1445-58. PubMed ID: 25921407 [TBL] [Abstract][Full Text] [Related]
9. Pharmacology of Valinate and tert-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and Their Analogues. Banister SD; Longworth M; Kevin R; Sachdev S; Santiago M; Stuart J; Mack JB; Glass M; McGregor IS; Connor M; Kassiou M ACS Chem Neurosci; 2016 Sep; 7(9):1241-54. PubMed ID: 27421060 [TBL] [Abstract][Full Text] [Related]
10. Novel halogenated derivates of JWH-018: Behavioral and binding studies in mice. Vigolo A; Ossato A; Trapella C; Vincenzi F; Rimondo C; Seri C; Varani K; Serpelloni G; Marti M Neuropharmacology; 2015 Aug; 95():68-82. PubMed ID: 25769232 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological and Toxicological Effects of Synthetic Cannabinoids and Their Metabolites. Tai S; Fantegrossi WE Curr Top Behav Neurosci; 2017; 32():249-262. PubMed ID: 28012093 [TBL] [Abstract][Full Text] [Related]
12. Functional effects of synthetic cannabinoids versus Δ Schreiber S; Bader M; Lenchinski T; Meningher I; Rubovitch V; Katz Y; Cohen E; Gabet Y; Rotenberg M; Wolf EU; Pick CG Addict Biol; 2019 May; 24(3):414-425. PubMed ID: 29423994 [TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo pharmacology of nine novel synthetic cannabinoid receptor agonists. Marusich JA; Gamage TF; Zhang Y; Akinfiresoye LR; Wiley JL Pharmacol Biochem Behav; 2022 Oct; 220():173467. PubMed ID: 36154844 [TBL] [Abstract][Full Text] [Related]
14. Application of an activity-based receptor bioassay to investigate the in vitro activity of selected indole- and indazole-3-carboxamide-based synthetic cannabinoids at CB1 and CB2 receptors. Noble C; Cannaert A; Linnet K; Stove CP Drug Test Anal; 2019 Mar; 11(3):501-511. PubMed ID: 30280499 [TBL] [Abstract][Full Text] [Related]
15. Δ(9)-Tetrahydrocannabinol-like effects of novel synthetic cannabinoids in mice and rats. Gatch MB; Forster MJ Psychopharmacology (Berl); 2016 May; 233(10):1901-10. PubMed ID: 26875756 [TBL] [Abstract][Full Text] [Related]
16. 1-Pentyl-3-phenylacetylindoles and JWH-018 share in vivo cannabinoid profiles in mice. Wiley JL; Marusich JA; Martin BR; Huffman JW Drug Alcohol Depend; 2012 Jun; 123(1-3):148-53. PubMed ID: 22127210 [TBL] [Abstract][Full Text] [Related]
17. Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on "tetrad", sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies. Canazza I; Ossato A; Trapella C; Fantinati A; De Luca MA; Margiani G; Vincenzi F; Rimondo C; Di Rosa F; Gregori A; Varani K; Borea PA; Serpelloni G; Marti M Psychopharmacology (Berl); 2016 Oct; 233(21-22):3685-3709. PubMed ID: 27527584 [TBL] [Abstract][Full Text] [Related]
18. Molecular and Behavioral Pharmacological Characterization of Abused Synthetic Cannabinoids MMB- and MDMB-FUBINACA, MN-18, NNEI, CUMYL-PICA, and 5-Fluoro-CUMYL-PICA. Gamage TF; Farquhar CE; Lefever TW; Marusich JA; Kevin RC; McGregor IS; Wiley JL; Thomas BF J Pharmacol Exp Ther; 2018 May; 365(2):437-446. PubMed ID: 29549157 [TBL] [Abstract][Full Text] [Related]